533 / 1245
Why are we interested in out of field dose?
• Success of RT means longer survival of patients (Second Primary)
• New treatment techniques (VMAT)
• Improved optimisation based on DVC’s
• Peripheral doses to IED’s
• Differences in TPS?
3